APOG
Apogee Enterprises, Inc.
APOG has the edge over BA overall on the model score.
BA
The Boeing Company
BA has slightly lower modeled downside risk, despite its lower overall score.
APOG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
APOG's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
APOG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $33.73 | -29% |
| Forward | 14x | $47.41 | — |
| Fair | 15x | $46.28 | -2.4% |
| Current | 15x | $47.41 | — |
| Expensive | 44x | $139 | +193% |
Historical ranges are pointers, not guarantees.
APOG's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over APOG in the historical PE scenario, which offers more potential upside but is not a forecast.
APOG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for APOG, with profitability holding steady.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over APOG on the outlook, with more favorable profitability expectations.
APOG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.37 | +6.6% |
| Q3 2026 | $3.16 | +54% |
| Q2 2026 | $3.19 | +36% |
| Q1 2026 | $2.52 | -35% |
| Q4 2025 | $1.86 | -58% |
| Q3 2025 | $2.05 | -57% |
| Q2 2025 | $2.35 | -52% |
| Q1 2025 | $3.89 | -14% |
| Q4 2024 | $4.48 | -4.5% |
APOG's earnings per share have fallen from their peak: $3.16 over the past year, against $4.87 in mid-2024.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over APOG on earnings, with more consistent year-over-year improvement.
APOG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $391.1M | +9.2% |
| Q2 2026 | $342.7M | -1.1% |
| Q1 2026 | $351.4M | +1.6% |
| Q4 2025 | $348.6M | +2.1% |
| Q3 2025 | $358.2M | +4.6% |
| Q2 2025 | $346.6M | +4.6% |
| Q1 2025 | $345.7M | -4.5% |
| Q4 2024 | $341.3M | +0.5% |
APOG's revenue grew through 2022 and has held roughly level since: $391M last quarter, up 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | +1.1 points |
| Q2 2026 | 5.5% | +3.5 points |
| Q1 2026 | 7.3% | +5.6 points |
| Q4 2025 | 7.1% | -1.3 points |
| Q3 2025 | 7.5% | -4.7 points |
| Q2 2025 | 2% | -11 points |
| Q1 2025 | 1.8% | -4.3 points |
| Q4 2024 | 8.4% | -2.7 points |
APOG has the edge over BA on profitability, with a higher operating margin.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over APOG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
APOG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.3M | -54% |
| Q2 2026 | $1.1M | +$28.1M |
| Q1 2026 | $46.9M | +145% |
| Q4 2025 | $22.9M | +4.1% |
| Q3 2025 | $52.4M | +4.3% |
| Q2 2025 | -$26.9M | -$25.2M |
| Q1 2025 | $19.1M | -67% |
| Q4 2024 | $22M | -60% |
APOG still generates free cash flow, though less than at its 2024 peak: $95M over the past year.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over APOG on cash flow, with more consistent year-over-year improvement.
APOG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -411K shares |
| 1 year | -3.2% | -689K shares |
| 3 years | -4.8% | -1.1M shares |
| 5 years | -17% | -4.2M shares |
| Available history | -22% | -5.8M shares |
APOG has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.4M |
| Q2 2026 | $9.7M |
| Q1 2026 | $15M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $30.3M |
| Q4 2024 | — |
APOG spent $31M buying back its own shares over the past year, up 2.6% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
APOG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.3x | Healthy |
APOG has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
APOG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.6 | Neutral |
| Stochastic | 85.8 | Overbought |
APOG's weekly RSI is 64 (neutral) and its Stochastic is 86 (overbought).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
APOG PE vs Industrials Sector
| Metric | APOG | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 24x | 38% below |
| PE % | 52 | 58 | 6 pts below |
APOG has the edge over BA on valuation relative to its sector.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
APOG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.1 | 13% above |
| 20 week MA | $41.0 | 16% above |
| 50 week MA | $39.0 | 22% above |
| 100 week MA | $42.0 | 13% above |
| 200 week MA | $48.7 | 2.6% below |
APOG has the edge over BA on trend strength, trading above more of its moving averages.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
APOG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.5 | $32.7 | +0.5% |
| 2021 | $32.7 | $47.2 | +44% |
| 2022 | $47.2 | $43.9 | -7% |
| 2023 | $43.9 | $53.4 | +22% |
| 2024 | $53.4 | $72.3 | +35% |
| 2025 | $72.3 | $38.0 | -48% |
| 2026 YTD | $38.0 | $47.4 | +25% |
APOG has the edge over BA on returns for 2026, with the stronger performance.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.